Bystronic (BYS) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
9 Apr, 2026Executive summary
Order intake rose 5% at constant exchange rates to CHF 634.5 million, while net sales declined 2.2% year-over-year at constant exchange rates, reaching CHF 613.2 million.
Profitability improved significantly, with adjusted EBIT loss reduced by 76.4% versus 2024, driven by restructuring and cost reductions, and adjusted EBIT (excluding one-offs) improving to CHF 47 million.
Restructuring delivered CHF 60 million in annualized savings, with 600+ FTEs reduced and 85% of savings realized in 2024/25.
Strategic focus shifted toward Smart Factories, automation, and larger system projects, positioning for future market recovery.
Strong cash position maintained, with cash and securities at CHF 330.7 million and an equity ratio of 70% at year-end.
Financial highlights
EBIT improved to CHF -19.8 million from CHF -84.0 million in the prior year, reflecting lower operating costs.
Net result improved to CHF -28.9 million from CHF -67.6 million year-over-year.
Operating free cash flow was CHF -18.8 million, impacted by restructuring-related outflows.
Dividend maintained at CHF 4.00 per class A registered share, with a total payout of CHF 8.3 million proposed.
Regional sales mix: 50% Europe, 35% North America, 15% APAC plus China.
Outlook and guidance
No significant improvement in the overall market environment expected for 2026; focus remains on project business and Smart Factories.
Net sales anticipated to increase in 2026, supported by a higher backlog and contributions from Bystronic Rofin.
Midterm EBIT margin guidance of 5–7% reiterated.
Profitability in 2026 depends on timing of net sales recognition from project deliveries.
Ongoing cost base improvements, but no further large-scale restructuring planned.
Latest events from Bystronic
- Order intake and sales fell, but order backlog rose sharply amid ongoing market uncertainty.BYS
Q1 2026 TU16 Apr 2026 - Order intake and sales fell nearly 30%, leading to a record EBIT loss and no recovery expected.BYS
H1 20243 Feb 2026 - Sharp sales and earnings decline led to major restructuring and persistent market headwinds.BYS
H2 202420 Dec 2025 - Order intake stabilized, EBIT loss narrowed 66%, and CHF 60m cost savings are on track.BYS
H1 202516 Nov 2025 - Order intake stable, sales down, with improved operating results expected for 2025.BYS
Q3 2025 TU23 Oct 2025 - Order intake and sales dropped over 25% as restructuring accelerates amid weak demand.BYS
Q3 2024 TU13 Jun 2025